✦ LIBER ✦

436 Renal safety of intravenous ibandronate with short infusion times

✍ Scribed by M. Pecherstorfer; I. Diel; D. Tripathy; B. Bergstrom

Book ID: 118620610
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 171 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(03)90468-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Renal Safety of Intravenous Ibandronic A

Renal Safety of Intravenous Ibandronic Acid in Breast Cancer Patients with Metastatic Bone Disease

✍ Dr Nina V. Lyubimova, Nikolay E. Kushlinsky, Michail R. Lichinitser, Karl Schlos 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 114 KB

Renal safety of ibandronate 6 mg intrave

Renal safety of ibandronate 6 mg intravenously administered with shortened infusion times (15 and 30 minutes) in human volunteers: higher peak concentrations do not result in adverse renal effects

✍ G. Neugebauer; W. Köhler; L. Akinkunmi; J. Pinner; H. Kletzl; L. Banken 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Safety of Intravenous Gadolinium (Gd-BOP

Safety of Intravenous Gadolinium (Gd-BOPTA) Infusion in Patients With Renal Insufficiency

✍ Raymond R. Townsend; Debbie L. Cohen; Richard Katholi; Suzanne K. Swan; Brian E. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Renal safety profile of ibandronate 6mg

Renal safety profile of ibandronate 6mg infused over 15 or 60 min in breast cancer patients with bone metastases

✍ F. Schütz; R. von Moos; C.B. Caspar; R. Angst; R. Inauen; R. Greil; J. Ziegler; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Safety and efficacy of subcutaneous and

Safety and efficacy of subcutaneous and continuous intravenous infusion rIL-2 in patients with metastatic renal cell carcinoma

✍ Geertsen, P F; Gore, M E; Negrier, S; Tourani, J M; von der Maase, H 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

Renal safety of ibandronate 6 mg infused

Renal safety of ibandronate 6 mg infused over 15 min versus 60 min in breast cancer patients with bone metastases: A randomized open-label equivalence trial

✍ Xavier Pivot; Alain Lortholary; Sophie Abadie-Lacourtoisie; Fawzia Mefti-Lachera 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 183 KB